Aerpio Pharmaceuticals, Inc. (ARPO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.2700-0.0800 (-5.93%)
At close: 4:00PM EDT
1.2600 -0.01 (-0.79%)
After hours: 6:44PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 1.3500 |
| Open | 1.3300 |
| Bid | 1.2700 x 2200 |
| Ask | 1.2700 x 1800 |
| Day's Range | 1.2400 - 1.3300 |
| 52 Week Range | 0.4920 - 2.3100 |
| Volume | 638,803 |
| Avg. Volume | 2,043,067 |
| Market Cap | 60.088M |
| Beta (5Y Monthly) | 1.73 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1010 |
| Earnings Date | Mar 11, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.75 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Zacks
QIAGEN's (QGEN) NeuMoDx Multiplex Test Receives FDA EUA
QIAGEN's (QGEN) new NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage test strengthens the company's portfolio in PCR testing, while becoming a crucial diagnostic tool for the flu season and the pandemic.
- Zacks
Aerpio Pharmaceuticals (ARPO) Is in Oversold Territory: What's Next?
Aerpio Pharmaceuticals (ARPO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
- Zacks
What Makes Aerpio Pharmaceuticals, Inc. (ARPO) a New Buy Stock
Aerpio Pharmaceuticals, Inc. (ARPO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2021 Verizon Media. All rights reserved.
